We have simply taken too long to get to the point we are at now,boy who cried wolf to an extent. Pharma/Bio picks are cocktail party plays,anyone can explain them in one paragraph, we are not that. It is frustrating to see companies like ASTC triple with a single patent, when we have been cranking out several and are miles ahead relative to approvals and production.
We'll get there yet,just not sure when.
News 
Market Data 
Discover 
AI
